Genmab — Oktober 2018
-
Jeg kan godt se visse ligheder. Prostvac resultater kom senere end ventet og det blev positivt udlagt. Det var det ikke. MAIA kommer senere end ventet og det bliver positivt udlagt. Men ellers er det da meget anderledes. Men lidt træls fra investorsynspunkt at man ikke kan vide hvorfor forsøget ikke er afsluttet til forventet tidspunkt.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind